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ABSTRACT 
 
Background Little is known about whether patterns of growth are associated with altered respiratory 
and immune development. This study relates prenatal and infant growth patterns to wheeze and atopy at 
age 3 years 
Methods Birth weight and length were measured in 1548 children born at term. Conditional fetal 
head and abdominal circumference growth velocities were calculated from antenatal ultrasound 
measurements. Conditional postnatal growth velocities were calculated from infant weight, length and 
adiposity data. .Measures of size and conditional growth were related to parentally-reported infant and 
early childhood wheeze and to atopic status at age 3. 
Results  Atopy risk increased by 46% per standard deviation (SD) increase in abdominal 
circumference growth velocity from 11-19 weeks’ gestation but by 20% per SD decrease in abdominal 
growth velocity from 19-34 weeks (p=0.007 and p=0.011). Atopic wheeze risk increased by 20% per SD 
decrease in 19-34 week abdominal growth (p=0.046). Non-atopic wheeze risk increased by 10% per SD 
decrease in 11-19 week head circumference growth. Greater relative infant weight and adiposity gains 
were associated with both atopic and non-atopic wheeze. 
Conclusions Rapid growth during 11-19 weeks’ gestation followed by growth faltering is associated 
with atopy, suggesting that influences affecting fetal growth may also alter immune development. A 
lower early fetal growth trajectory is associated with non-atopic wheeze, possibly reflecting an 
association with smaller airways. An association between postnatal adiposity gain and wheeze may 
partly reflect prenatal influences that cause fetal growth to falter but are then followed by postnatal 
adiposity gain.
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INTRODUCTION 
Children and adults who were small at birth tend to have reduced lung function and an increased risk of 
respiratory mortality and morbidity.[1-3 ] Smaller birth size is associated with reduced lung function 
from early infancy,[1-7] and genetic and environmental influences on early lung development appear to 
have lasting effects on later respiratory health.[8] It has been proposed that an adverse intrauterine 
environment might induce fetal adaptations which restrict somatic growth and also have adverse 
functional consequences for the developing immune system and lungs.[3]  
 
Studies examining the association between birth anthropometry and later asthma have, however, had 
inconsistent findings [2] and children who had experienced intrauterine growth retardation (IUGR) had 
decreased lung function but no difference in wheeze compared with children who were appropriate 
weight for gestational age at birth.[1] The inconsistent findings may partly reflect methodological 
differences including adequacy of correction for gestation and other confounding factors. In twin studies 
birth weight exerts a greater influence upon later asthma in monozygotic than in dizygotic twin pairs, 
suggesting fetal growth and childhood asthma may be associated independently of shared genetic 
factors.[9;10]  
 
In healthy term infants within the normal birth weight range, we previously found that smaller birth size 
and rapid postnatal weight gain were associated with reduced lung function at age 5-14 weeks.[4] 
Subsequent studies showed an inverse relationship between infant lung function and early postnatal 
weight gain in premature infants,[5] and that lung function at 1 and 12 months is inversely related to 
infant weight gain.[11] Rapid postnatal weight gain can result from prenatal growth restriction, and we 
hypothesised that faltering growth in late gestation might be associated with later respiratory ill-
health.[4]  
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Studies to date have generally used birth anthropometry as a proxy for fetal growth and no previous 
study in an unselected population has utilised detailed characterisation of pre- and postnatal growth 
patterns from longitudinal anthropometric data collected before and after birth. Here we measured fetal 
size longitudinally and derived conditional head and abdominal circumference growth velocities to 
assess both the early trajectory of fetal growth and faltering of abdominal growth in late gestation; the 
latter is recognised as an important fetal adaptation to an adverse intrauterine environment which acts to 
protect brain growth.[12,13] We also derived conditional velocities of postnatal weight and adiposity 
gain, because faltering of prenatal growth may lead to an increased rate of infant weight gain. We then 
examined the relationships between antenatal and postnatal growth parameters and early childhood 
wheeze and atopy.  
 
METHODS 
Study Population We studied offspring of Southampton Women’s Survey participants.[14] Between 
1998-2002, 12,583 women aged 20-34 years were recruited; those who became pregnant were followed 
through pregnancy and their children visited at 6, 12, 24 and 36 months. We excluded infants born at 
<37 weeks’ gestation to avoid confounding effects of abnormal lung development associated with 
prematurity. By December 2003, 1868 term infants were born; 1548 (83%) were followed up at age 3 
years, with 98% seen at all four postnatal visits.  
 
Growth Variables Gestational age was determined using an algorithm combining the mother’s last 
menstrual period and early ultrasound data. Using Acuson 128 XP, Aspen & Sequoia ultrasound 
machines calibrated to 1540 m/s experienced research ultrasonographers used standardised anatomical 
landmarks to measure fetal head and abdominal circumferences at 11, 19 and 34 weeks’ gestation. 
Research nurses measured weight and crown-heel length at birth, and weight, length and subscapular 
skinfold thickness at 6 and 12 months.  
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Respiratory Symptoms At 6, 12, 24 and 36 months mothers were asked whether their child had 
‘experienced any episodes of chestiness associated with wheezing or whistling in his/her chest since they 
were last seen’. A positive response on any postnatal visit was considered evidence of early childhood 
wheeze.  
 
Atopic Status  Atopy at age 3 years was defined as skin prick test reactivity to any allergen (cata, 
doga, house dust mitea , milka, grass pollensa, and eggb (Hollister-Stier, Spokane, WAa; Alyostal, Antony, 
Franceb) ≥3mm in diameter in the presence of appropriate positive and negative controls. Maternal 
atopic status was assessed at the 12-month interview. 
 
Statistical Analysis The method of Royston was used to calculate conditional measures of fetal size 
and infant length and weight, correcting for the exact age at measurement and regression to the 
mean.[15] Velocities of prenatal and infant growth were calculated from change in size adjusted for 
gestation or age, as appropriate. For subscapular skinfold thickness, the method of Royston proved 
unsuitable as adiposity does not increase monotonically with age; subscapular skinfold growth velocity 
conditional upon initial size was calculated using regression. Anthropometric and growth velocity 
variables were logarithmically transformed to achieve a normal distribution, then standardised to z-
scores. Outcomes in these cases were expressed in units of change in outcome per SD change in 
predictor. All outcome variables were binary but common; therefore Poisson regression with robust 
variance was used to derive relative risks. Logistic regression was not used as odds ratios relating to 
common outcomes are hard to interpret.[16]  
 
Relative risks were determined for two primary outcomes: ‘early childhood wheeze’ and ‘atopy’, 
comparing children with and without each condition. Children who were reported to wheeze were 
divided according to atopic status to form two secondary outcomes ‘atopic wheeze’ and ‘non-atopic 
wheeze’; children in these groups were compared with non-atopic children who had never wheezed. 
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Online Table 1 shows potential confounders examined. Regression models were built including 
confounders significantly associated with each outcome in a mutually-adjusted model (p<0.05) and key 
factors thought essential to adjust for because of potential biological significance (maternal education, 
maternal atopy and child’s birth order for atopy at 3 years and atopic wheeze; maternal education, 
smoking in pregnancy, maternal asthma, paternal asthma and child’s birth order for early childhood 
wheeze and non-atopic wheeze). Adjusted and unadjusted relative risks are presented for birth 
anthropometry and pre and postnatal growth velocities; relative risks for static measures of fetal size are 
presented in the online supplement. Analyses were performed using Stata™ 8.2 (StataCorp, Texas).  
 
RESULTS 
Table 1 shows the wide variation in the characteristics of the children seen at 3 years. Cohort members 
not seen had lower mean birth weight, and their mothers were younger, more likely to smoke, less likely 
to have tried breastfeeding and had lower educational attainment.  
 
Wheeze status to age 3 years was known for 1522 children (98%); 890 children (58%) had ever 
experienced wheeze. Atopic status was known for 1342 mothers (87%) and 1184 children (76%); 199 
children (17%) were atopic. Both wheeze and atopy data were available for 1164 children; of these 127 
(11%) had wheezed and were atopic, 555 (48%) had wheezed but were not atopic, 67 (6%) had never 
wheezed but were atopic and 415 (36%) had never wheezed and were not atopic (Figure 1).  
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Table 1. Characteristics of children who were and were not seen at age 3 years  
 
Parental characteristics 
Children seen at 3 
years (n=1548) 
Children not seen at 3 
years (n=320) 
P-value 
Mother’s age at child’s birth (years), mean (SD) 30.2 (3.8) 29.4 (3.8) 0.001 
Mother’s educational A Level or above, n (%) 900 (57%) 150 (47%) <0.001 
Maternal smoking during pregnancy, n (%) 245 (16%) 80 (27%) <0.001 
Maternal asthma, n (%) 344 (22%) 74 (24%) 0.599 
Maternal eczema in childhood, n (%) 275 (18%) 50 (16%) 0.432 
Maternal rhinitis, n (%) 639 (42%) 118 (38%) 0.225 
Paternal asthma, n (%) 264 (17%) 60 (20%) 0.567 
Paternal eczema in childhood, n (%) 156 (11%) 31 (10%) 0.897 
Paternal rhinitis, n (%) 506 (34%) 102 (34%) 0.883 
      
Birth characteristics       
Birth weight (g), mean (SD) 3525 (475) 3456 (467) 0.020 
Gestational age (weeks), mean (SD) 40.1 (1.2) 40.1 (1.2) 0.909 
Primiparous, n (%) 704 (46%) 114 (36%) 0.001 
Attempted breastfeeding, n (%)* 1269 (83%) 162 (70%) 0.000 
      
Characteristics at 6 month follow-up*      
Maternal smoking, n (%) 284 (18%) 73 (30%) <0.001 
Other smokers in the home, n (%) 461 (31%) 86 (35%) 0.145 
Ever wheezed, n (%) 402 (26%) 83 (34%) 0.013 
Cat or dog in home, n (%) 699 (45%) 105 (43%) 0.384 
      
Characteristics at 1 year follow-up*      
Wheezed in past 6 months, n (%) 464 (30%) 80 (41%) 0.002 
Cat or dog in home, n (%) 675 (44%) 82 (42%) 0.575 
      
Characteristics at 2 year follow-up*      
Wheezed in past year, n (%) 414 (27%) 28 (27%) 0.954 
 
* Of the 320 children not seen at 3 years, 247 were seen at 6 months, 196 at 1 year and 104 at 2 years 
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Early childhood wheeze 
 
Early childhood wheeze was not significantly associated with either fetal measurements (Online Table 2) 
or birth weight or length (Table 2), but was associated with greater weight and adiposity gains both 
between birth and 6 months (5% per SD increase, p= 0.02 for both) and from 6-12 months (6% per SD 
increase in weight, p=0.04 and 7% per SD increase in adiposity gain, p=0.001). There was no association 
between early childhood wheeze and postnatal length gain. 
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Table 2. Relative risks (RR) for the associations between pre- and postnatal growth and whether the 
child had ever wheezed by age 3 years (unadjusted and adjusted)  
 Unadjusted analyses Adjusted* analyses 
 RR (95% CI) P-value n RR (95% CI) P-value n 
Birth size variables         
Crown-heel length  0.96 0.92-1.00 0.061 1479 0.96 0.92-1.01 0.088 1479 
Weight  0.97 0.93-1.01 0.197 1506 0.97 0.93-1.02 0.206 1506 
         
Conditional fetal growth         
11-19 weeks         
Head circumference  0.98 0.91-1.06 0.574 597 0.94 0.87-1.02 0.155 597 
Abdominal circumference  0.98 0.89-1.07 0.611 562 0.95 0.87-1.04 0.285 562 
         
19-34 weeks         
Head circumference  0.98 0.93-1.04 0.598 877 0.98 0.93-1.04 0.572 877 
Abdominal circumference  1.04 0.99-1.10 0.129 911 1.04 0.99-1.10 0.092 911 
         
Conditional Infant growth          
0 – 6 months         
Length  1.01 0.97-1.05 0.574 1450 0.98 0.94-1.03 0.409 1450 
Weight  1.08 1.03-1.12 0.000 1485 1.05 1.01-1.09 0.020 1485 
Subscapular skinfolds  1.06 1.02-1.10 0.003 1480 1.05 1.01-1.10 0.017 1480 
         
6 – 12 months         
Length  0.97 0.93-1.02 0.307 1346 0.98 0.93-1.04 0.579 1346 
Weight   1.04 0.98-1.09 0.190 1372 1.06 1.00-1.12 0.041 1372 
Subscapular skinfolds 1.06 1.01-1.10 0.010 1368 1.07 1.03-1.12 0.001 1368 
         
N = 1522 
*Adjusted for gender, smoking during pregnancy, age last breastfed, maternal asthma, maternal rhinitis, 
paternal asthma, maternal education and birth order. 
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Atopy at age 3 years 
The relative risk of atopy at 3 years increased by 46% per SD increase in abdominal circumference 
growth velocity from 11-19 weeks’ gestation (p=0.007) (Table 3), and was higher in children who had a 
larger abdominal circumference at 19 weeks’ gestation (RR=1.24 per SD increase in abdominal 
circumference, p=0.02) (Online Table 3). In contrast, each SD increase in abdominal growth velocity 
from 19-34 weeks’ gestation decreased atopy risk by 20% (p=0.01) (Table 3). Atopy risk was associated 
with greater crown-heel length at birth (RR=1.17 per SD, p=0.03) but not with prenatal head 
circumference growth, birth weight or measures of postnatal growth velocity. Results were similar when 
sensitisation to food allergens was excluded from the definition of atopy. 
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Table 3. Adjusted relative risks (RR) for the associations between fetal and infant growth and atopy at 
age 3 years  
 Unadjusted analyses Adjusted* analyses 
 RR (95% CI) P-value n RR (95% CI) P-value n 
Birth size variables         
Crown-heel length  1.20 1.06-1.36 0.005 1149 1.17 1.01-1.34 0.032 1004 
Weight  1.10 0.97-1.25 0.137 1171 1.08 0.95-1.24 0.241 1023 
         
Conditional fetal growth         
11-19 weeks         
Head circumference  0.93 0.72-1.18 0.534 464 0.80 0.60-1.06 0.123 405 
Abdominal 
circumference  
1.44 1.20-1.86 0.005 431 1.46 1.11-1.93 0.007 378 
         
19-34 weeks         
Head circumference  0.96 0.81-1.13 0.608 682 0.98 0.82-1.17 0.817 601 
Abdominal 
circumference  
0.80 0.69-0.94 0.006 707 0.80 0.68-0.95 0.011 625 
         
Conditional Infant 
growth  
        
0 – 6 months         
Length  0.93 0.83-1.05 0.244 1131 0.89 0.78-1.02 0.104 991 
Weight  1.09 0.97-1.22 0.131 1157 1.06 0.92-1.21 0.416 1013 
Subscapular skinfolds  1.09 0.97-1.23 0.157 1153 1.09 0.96-1.24 0.185 1011 
         
6 – 12 months         
Length  1.08 0.93-1.26 0.326 1069 1.02 0.86-1.21 0.843 941 
Weight   1.00 0.83-1.19 0.961 1086 1.03 0.84-1.26 0.778 956 
Subscapular skinfolds  1.05 0.92-1.20 0.485 1078 1.11 0.97-1.27 0.142 950 
         
N = 1184; *Adjusted for gender, maternal eczema, maternal atopy, maternal education and birth order 
 
 
Atopic wheeze 
The pattern of risk for atopic wheeze was similar to that for atopy (Tables 3 and 4). Relative risk 
increased with higher 11-19 week abdominal growth velocity (32% per SD, p=0.1), larger 19 week fetal 
abdominal circumference (34% increase per SD, p=0.02) (Online Table 4), and lower 19-34 week 
abdominal growth velocity (20% per SD, p=0.046). Atopic wheeze risk was not associated with prenatal 
head circumference growth, weight or crown heel length at birth (p=0.3) (Online Table 4), but was 
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associated with greater weight and adiposity gain in infancy (Table 4). SD increases in subscapular 
skinfold gain and weight gain between birth and 6 months were associated with 27% and 22% increases 
in atopic wheeze risk (p=0.002 and p=0.02, respectively); each SD increase in subscapular skinfold gain 
between 6 and 12 months was associated with a 20% increase in atopic wheeze risk (p=0.02). In 
contrast, postnatal length gain was not associated with atopic wheeze risk. 
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Table 4. Relative risks (RR) for the associations between pre- and postnatal growth and whether the 
child had ever wheezed by age 3 years and was atopic, compared with children who had never wheezed 
and were not atopic (unadjusted and adjusted)   
 Unadjusted analyses Adjusted* analyses 
Birth size variables         
Crown-heel length  1.09 0.94-
1.26 
0.247 527 1.08 0.93-
1.26 
0.313 456 
Weight  1.06 0.91-
1.23 
0.461 537 1.02 0.87-
1.19 
0.810 465 
         
Conditional fetal growth         
11-19 weeks         
Head circumference  0.96 0.69-
1.33 
0.818 207 0.79 0.54-
1.15 
0.216 183 
Abdominal 
circumference  
1.42 1.05-
1.92 
0.024 197 1.32 0.94-
1.85 
0.114 172 
         
19-34 weeks         
Head circumference  0.98 0.80-
1.21 
0.866 308 0.88 0.69-
1.12 
0.294 276 
Abdominal 
circumference  
0.82 0.66-
1.01 
0.066 321 0.80 0.65-
1.00 
0.046 288 
         
Conditional Infant 
growth  
        
0 – 6 months         
Length  1.00 0.86-
1.16 
0.987 518 0.96 0.82-
1.12 
0.602 499 
Weight  1.25 1.09-
1.43 
0.001 530 1.22 1.03-
1.43 
0.020 460 
Subscapular skinfolds  1.22 1.07-
1.40 
0.004 533 1.27 1.09-
1.49 
0.002 463 
         
6 – 12 months         
Length  1.02 0.85-
1.22 
0.829 497 0.98 0.80-
1.20 
0.842 432 
Weight   1.14 0.92-
1.41 
0.234 504 1.19 0.94-
1.31 
0.147 438 
Subscapular skinfolds 1.14 0.99-
1.32 
0.073 502 1.20 1.03-
1.39 
0.018 436 
         
N = 542; *Adjusted for gender, smoking during pregnancy, maternal asthma and maternal rhinitis, maternal atopy, 
paternal asthma, maternal education and birth order. 
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Non-atopic wheeze 
The associations between fetal growth and risk of non-atopic wheeze differed from those for atopic 
wheeze. Non-atopic wheeze was not associated with higher 11-19 week abdominal growth velocity 
followed by abdominal growth faltering, but instead increases in risk were seen for lower head 
circumference growth velocity between 11 and 19 weeks (RR=0.90 per SD increase, p=0.04) (Table 5) 
and smaller 34-week head circumference (RR=0.91 per SD increase, p=0.02) (Online Table 5) .Similar 
to the associations for atopic wheeze, non-atopic wheeze risk increased by 6% per SD increase in 
adiposity gain from birth to 6 months (p=0.02) and by 8% per SD increase in weight gain between 6 and 
12 months (p=0.04) (Tables 5). Similarly to atopic wheeze, postnatal length gain was not associated with 
non-atopic wheeze risk. 
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Table 5. Relative risks (RR) for the associations between pre- and postnatal growth and whether the 
child had ever wheezed by age 3 years but was not atopic, compared with children who had never 
wheezed and were not atopic (unadjusted and adjusted) 
 Unadjusted analyses Adjusted* analyses 
 RR (95% CI) P-value n RR (95% CI) P-value n 
Birth size variables         
Crown-heel length  0.97 0.92-1.03 0.282 944 0.97 0.92-1.03 0.317 926 
Weight  0.98 0.93-1.04 0.486 960 0.97 0.92-1.03 0.356 942 
         
Conditional fetal growth         
11-19 weeks         
Head circumference  0.92 0.83-1.01 0.090 383 0.90 0.81-1.00 0.041 373 
Abdominal circumference  0.98 0.88-1.09 0.744 361 0.97 0.87-1.09 0.637 352 
         
19-34 weeks         
Head circumference  0.93 0.87-1.00 0.058 564 0.94 0.88-1.01 0.096 552 
Abdominal circumference  1.06 0.99-1.13 0.117 584 1.05 0.98-1.13 0.136 572 
         
Conditional Infant growth          
0 – 6 months         
Length  1.01 0.96-1.06 0.825 933 0.99 0.94-1.05 0.766 915 
Weight  1.05 1.00-1.10 0.044 952 1.04 0.99-1.10 0.093 934 
Subscapular skinfolds  1.07 1.02-1.12 0.009 950 1.06 1.00-1.11 0.024 932 
         
6 – 12 months         
Length  0.97 0.91-1.03 0.320 878 0.98 0.92-1.05 0.636 862 
Weight   1.04 0.97-1.11 0.289 891 1.08 1.00-1.15 0.036 876 
Subscapular skinfolds 1.00 0.95-1.06 0.929 887 1.02 0.96-1.09 0.465 871 
         
N = 970*Adjusted for gender, maternal age, smoking during pregnancy, maternal asthma, maternal 
rhinitis, paternal asthma, maternal education and birth order. 
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Simultaneous analyses 
 
The conditional measures of growth velocity were calculated to ensure that they were independent of 
initial size. Perhaps as a result, the relative risk ratios for atopy, atopic wheeze and non-atopic wheeze 
associated with measures of conditional prenatal abdominal growth and postnatal adiposity gain changed 
little after simultaneous inclusion of these growth measures in a multivariate analysis.  
 
Formal testing showed no significant linear interactions between conditional 11-19 and 19-34 week 
abdominal growth velocities, or between 19-34 week abdominal growth and birth to 6 months adiposity 
gain in their predictions of outcomes. Subjects were grouped into thirds of growth velocity over the 
different time periods. The prevalences of childhood atopy and atopic wheeze were 27% and 38%, 
respectively, in those in the top third of abdominal growth velocity from 11-19 weeks gestation and the 
bottom third of growth velocity in late pregnancy, indicating growth faltering in late pregnancy; 
comparable prevalences in those in the bottom third of abdominal growth velocity from 11-19 weeks 
gestation and the top third of growth velocity in late pregnancy were 4% and 6% for childhood atopy 
and atopic wheeze respectively (Figure 2). The association of postnatal adiposity gain with atopic 
wheeze was strongest in those with below average late pregnancy abdominal growth (Online Table 6); 
the prevalence was 35% in those in the bottom third of late pregnancy abdominal growth velocity and 
the top third of adiposity gain from birth to 6 months, as compared with 14% in those in the top third of 
late pregnancy abdominal growth velocity and the bottom third of early infancy adiposity gain. For non-
atopic wheeze the prevalence was 68% in those in the bottom third of 19-34 week head circumference 
growth velocity and the top third of adiposity gain from birth to 6 months, compared with 41% in those 
in the top third of 19-34 week head circumference growth velocity and the bottom third of early infancy 
adiposity gain (Figure 3), with a similar pattern for adiposity gain from age 6-12 months (Figure 3). 
 
Infant feeding 
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As in other studies, formula-fed SWS infants had greater infant weight and adiposity gains than those 
breast-fed.[17] Stratified analyses showed, however, that the associations of infant weight and adiposity 
gains with early childhood wheeze, atopic and non-atopic wheeze, were similar in breast and formula-
fed infants. 
 
DISCUSSION  
Using conditional pre and postnatal growth velocities calculated from serial measurements of fetal and 
infant anthropometry we examined the influences of pre- and postnatal growth on wheeze and atopy at 
age 3 years. Rapid 11-19 week fetal abdominal growth followed by faltering of abdominal 
circumference growth was associated with later atopy, and late gestation abdominal growth faltering 
associated with atopic wheeze. A lower early trajectory of prenatal head circumference growth was 
associated with non-atopic wheeze. Postnatal adiposity gain, but not linear growth, was associated with 
both atopic and non-atopic wheeze. The associations were independent of birth order, gestation, 
maternal atopy and smoking. These findings support our previous hypothesis that trajectories of growth 
before and after birth are associated with childhood respiratory health.[4] Although wheezing and atopic 
disorders have overlapping and mixed phenotypes, our analyses suggest that factors which promote 
adaptive change in the relative growth of body tissues during fetal life and infancy can have later 
functional respiratory and immune consequences.  
 
Prenatal growth and wheeze and atopic outcomes 
In our analyses, faster abdominal growth velocity from 11-19 weeks gestation followed by growth 
faltering in late pregnancy was associated with later atopy. This suggests that the development of atopy 
is influenced by factors causing growth restriction in late gestation. Under conditions of intrauterine 
stress or restricted placental nutrient transfer in late gestation, brain growth is generally preserved at the 
expense of reduced accretion of abdominal soft tissue and fat.[18] This results in asymmetrical growth 
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restriction, which is particularly marked in fetuses that initially follow a rapid growth trajectory.[12] 
Atopy is believed to result from a predominant Th2 lymphocyte response to common antigens.[19] 
Animal studies demonstrate that poor fetal growth results in impaired thymic development[20] and a 
Th1/Th2 imbalance.[21] Correlations between seasonal patterns of food availability and infant thymus 
size,[22] cord blood lymphocyte count[23] and infectious deaths in young adulthood[24] provide 
evidence for prenatal influences on human immune function.  
 
Whereas atopic wheeze was also associated with faltering of abdominal circumference, non-atopic 
wheeze was associated with slower head circumference growth from both 11-19 and 19-34 weeks’ 
gestation; children that developed non-atopic wheeze were not however smaller at birth .This suggests 
slowed growth in early gestation may be mechanistically linked to later wheeze susceptibility. Early or 
extreme adversity might be associated with both slowed head growth and altered airway growth or 
alterations in respiratory mechanics that predispose to airway narrowing and wheeze during viral 
respiratory infections.  
 
Experimental data support the central hypothesis that lung development and later function is sensitive to 
factors associated with fetal growth restriction, notably fetal hypoxaemia, reduced nutrient supply and 
hypercortisolaemia. For example, prenatal growth restriction in sheep is associated with a reduced lung 
weight to bodyweight ratio,[25] reduced alveoliarisation[26] and reduced airway luminal area and 
airway wall cartilage.[27] Growth restricted fetal lambs have altered lung structure[26] and decreased 
respiratory and increased chest wall compliance[28] which persist into postnatal life. 
 
Postnatal growth and wheeze and atopic outcomes 
The relative risk of atopy was not related to postnatal growth and adiposity gain. In contrast, 
independently of infant feeding, increased weight and adiposity gain during infancy were associated 
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with an increased risk of wheezing before age 3 years. Similar associations were seen for both non-
atopic and atopic wheeze, although the effect size was greatest for atopic wheeze. The associations with 
weight and adiposity gain contrasted with the absence of associations with length gain. 
 
Above average postnatal weight gain may be associated with atopic wheeze risk because late pregnancy 
growth faltering (associated with atopy in our study) tends to be followed by “compensatory” increased 
postnatal weight gain unless the prenatal nutrient restriction has been severe or prolonged.[29] 
Alternatively, rather than serving as a marker of intrauterine growth restriction, above average postnatal 
weight gain may itself impair lung development. This is supported by the association between non-
atopic wheeze and increased postnatal adiposity gain. Other studies have shown links between asthma 
and both high BMI [30] and rapid increases in weight [31]; whilst this may reflect common risk factors, 
increased adiposity in infancy may be mechanistically important in the development of asthma. Potential 
mechanisms include genetic polymorphisms,[32] sex-specific hormonal changes,[30] direct mechanical 
effects on lung function,[33] altered immune response[34] and increased susceptibility to gastric 
reflux.[35]  
 
Strengths and limitations 
The concept that birth anthropometry might predict future risk of wheezing and allergic disorders has 
been the subject of much investigation but little consensus. This is unsurprising as birth measurements 
only provide indirect evidence of the intrauterine environment. A strength of this study is the detailed 
assessment of prenatal growth afforded by serial ultrasound scans in a substantial sample of children 
broadly representative of the general population. 
 
The principal limitations of this analysis arise from its observational nature and from the likely non-
homogeneity of the outcome groups; ‘early childhood wheeze’, for example, is likely to include children 
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who wheeze only with viral respiratory infections and a smaller subgroup who may later become 
persistent asthmatics. The strength of associations between risk factors and outcomes are likely to be 
lessened by such non-homogeneity. Our study was not equally powered in relation to all outcomes or 
predictors; for example, there were <150 children in the ‘atopic wheeze’ group and only 542 children 
contributed data to analyses of this outcome. Fewer children had complete data for conditional measures 
of prenatal growth than for birth anthropometry due the need for two measurements to calculate the 
former. Power was also reduced by missing data for some confounding influences, notably maternal 
atopic status.  
 
In conclusion, we describe a pattern of rapid 11-19 week fetal abdominal growth velocity followed by 
growth faltering which is associated with later atopy, and demonstrate that late gestation growth faltering 
is associated with atopic wheeze. This suggests immune development is sensitive to programming by the 
prenatal environment. Moreover, we describe an association between postnatal adiposity gain and 
wheezing disorders; this may partly arise from impaired fetal growth which predisposes to 
‘compensatory’ postnatal weight and adiposity gains, or may reflect mechanisms linked with adiposity 
per se. Slower prenatal growth was associated with non-atopic wheeze and we speculate this may reflect 
smaller airway size.  
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Figure legends 
 
Figure 1.  
Study outline and numbers included in outcome groups 
 
Figure 2 
Atopy and atopic wheeze prevalence at age 3 years according to groupings of 11-19 week and 19-
34 week abdominal circumference growth velocity, and according to 19-34 week abdominal 
circumference growth and adiposity gain between birth and 6 months. 
 
Figure 3.  
Non-atopic wheeze prevalence according to groupings of 19-34 week head circumference growth 
velocity and adiposity gain from birth - 6 months and 6 - 12 months.  
 
 
 
 
